You have no items in your shopping cart.
Juvelook 50 mg is an innovative hybrid collagen biostimulator that combines Poly-D,L-Lactic Acid (PDLLA) with non-crosslinked Hyaluronic Acid (HA) to improve skin quality, hydration, and elasticity. Designed for professional aesthetic treatments, Juvelook provides immediate skin hydration while gradually stimulating natural collagen production for long-lasting skin rejuvenation.
Its unique formulation helps improve fine lines, skin texture, enlarged pores, and acne scars while restoring a smoother, firmer, and more youthful-looking complexion.
Key Benefits
Stimulates natural collagen production
Provides deep skin hydration
Improves skin elasticity and firmness
Reduces the appearance of fine lines and wrinkles
Helps improve enlarged pores
Softens the appearance of acne scars
Enhances overall skin texture and radiance
Offers gradual, natural-looking rejuvenation
How It Works
Juvelook combines the immediate hydrating effect of Hyaluronic Acid (HA) with the long-term collagen-stimulating properties of Poly-D,L-Lactic Acid (PDLLA).
Following treatment:
Hyaluronic acid provides instant hydration and supports skin moisture.
PDLLA microparticles gradually stimulate fibroblasts to produce new collagen.
As collagen remodeling progresses, skin becomes firmer, smoother, and more elastic over time.
Results develop progressively over several weeks and continue to improve as new collagen forms.
Indications
Juvelook is suitable for improving:
Fine lines and superficial wrinkles
Dull, dehydrated skin
Enlarged pores
Acne scars
Loss of skin elasticity
Uneven skin texture
Early signs of skin aging
Treatment Areas
Juvelook may be used on:
Full face
Under-eye area
Tear trough
Cheeks
Forehead
Neck
Décolletage
Hands
Composition
Each package contains:
Poly-D,L-Lactic Acid (PDLLA): 50 mg
Non-crosslinked Hyaluronic Acid (HA)
The product is supplied with a dedicated diluent for reconstitution prior to administration.
Administration
Juvelook should be prepared and administered by qualified medical professionals according to the manufacturer's recommended protocol.
General guidelines include:
Reconstitute the powder with the supplied sterile solution.
Mix thoroughly until a homogeneous suspension is achieved.
Administer using the appropriate injection technique based on the treatment area.
Injection depth and technique should be selected according to patient anatomy and treatment goals.
Recommended Treatment Course
For optimal skin rejuvenation, treatments are commonly performed as a series of three sessions, spaced approximately 4–6 weeks apart.
Maintenance treatments may be recommended depending on individual skin condition and desired results.
Package Contents
1 vial containing 50 mg PDLLA
Sterile diluent
Instructions for use
Storage
Store below 30°C.
Do not freeze.
Keep away from direct sunlight and moisture.
Contraindications
Juvelook should not be used in individuals who:
Are under 18 years of age
Are pregnant or breastfeeding
Have a known allergy to any ingredient
Have active skin infections or inflammation at the treatment site
Have autoimmune disorders or other conditions where injectable treatments are contraindicated
Have open wounds or damaged skin in the treatment area
Important Notice
Juvelook 50 mg is intended for use only by licensed healthcare professionals trained in aesthetic injection procedures. The appropriate injection technique, treatment protocol, and dosage should be determined by the practitioner based on the patient's individual needs and the manufacturer's official instructions.
For bulk orders, we kindly ask you to get in touch with us.



